Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. HQY
HQY logo

HQY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
78.980
Open
78.260
VWAP
78.33
Vol
536.10K
Mkt Cap
6.71B
Low
77.450
Amount
41.99M
EV/EBITDA(TTM)
16.24
Total Shares
85.44M
EV
7.39B
EV/OCF(TTM)
17.80
P/S(TTM)
5.36
HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.
Show More

Events Timeline

(ET)
2026-02-17
16:10:00
HealthEquity Reaffirms Fiscal 2026 Outlook
select
2026-02-17
16:10:00
HealthEquity Reaffirms FY26 Revenue View of $1.3B-$1.31B
select
2026-02-17
16:10:00
HealthEquity HSA Accounts Rise to 10.6 Million
select
2026-01-12 (ET)
2026-01-12
09:00:00
HealthEquity Projects FY 2027 Revenue of $1.38B to $1.41B
select
2026-01-12
09:00:00
HealthEquity Confirms FY26 Guidance
select

News

Benzinga
6.0
02-17Benzinga
Wall Street Analysts Adjust Ratings
  • Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, reflecting varying market perspectives that could influence investor decisions and market sentiment.
  • Investor Focus: When considering buying Micron Technology (MU) stock, analysts' opinions are particularly crucial, and investors should pay attention to these rating changes to make informed investment choices.
  • Source of Updates: Comprehensive information on analyst rating changes, including upgrades and downgrades, can be found on our analyst ratings page, providing a thorough market insight.
  • Market Impact: Adjustments in analysts' ratings not only affect the performance of individual stocks but may also create fluctuations in overall market sentiment, prompting investors to closely monitor these changes to seize investment opportunities.
NASDAQ.COM
8.0
01-19NASDAQ.COM
White House Unveils Healthcare Plan to Slash Drug Prices and Transform Industry Dynamics
  • Drug Price Reform: The White House's unveiling of 'The Great Healthcare Plan' on January 15, 2026, aims to significantly reduce prescription drug prices through 'Most-Favored-Nation' pricing agreements, alleviating consumer burdens and reshaping the pharmaceutical market landscape.
  • Subsidy Shift: By redirecting insurance subsidies directly to consumers instead of insurers, the plan is expected to lower insurance costs and enhance consumer choice, thereby impacting the revenue models of traditional insurance companies.
  • Retail Pharmacy Gains: The proposal to allow more prescription drugs to be sold over-the-counter will directly boost sales for retail pharmacies like Walmart, increasing foot traffic and enhancing the profitability of their clinic operations.
  • Portfolio Reevaluation: Investors are advised to reassess their ETF portfolios, prioritizing companies that benefit from the new policies, such as HealthEquity and the iShares U.S. Pharmaceuticals ETF, while avoiding middlemen companies facing regulatory pressures.
NASDAQ.COM
2.0
01-12NASDAQ.COM
HealthEquity Inc (HQY) Shares Oversold with RSI at 28.8
  • Oversold Signal: HealthEquity Inc (HQY) shares dropped to $84.505 on Monday, with an RSI of 28.8, indicating that the recent heavy selling may be exhausting, potentially providing entry points for bullish investors.
  • Market Comparison: Compared to the S&P 500 ETF (SPY) with an RSI of 67.4, HQY's 28.8 RSI suggests relative weakness, which may attract investors looking for undervalued opportunities.
  • Historical Performance: HQY's 52-week low is $74.07 and high is $116.65, with the current trading price of $84.55 reflecting its performance within this range, prompting a reassessment by investors.
  • Investor Sentiment: While the stock is currently oversold, investors should cautiously evaluate market trends to avoid making impulsive decisions in an uncertain market environment.
NASDAQ.COM
4.5
01-10NASDAQ.COM
US Stock Market Rallies, S&P 500 Hits All-Time High
  • Strong Labor Market: The US unemployment rate fell to 4.4% in December, below the expected 4.5%, indicating labor market resilience and boosting investor confidence in economic recovery.
  • Wage Growth Exceeds Expectations: Average hourly earnings rose 3.8% year-over-year in December, surpassing the 3.6% forecast, which not only enhances consumer spending power but also supports economic growth.
  • Consumer Confidence Rebounds: The University of Michigan's January consumer sentiment index increased to 54.0, exceeding expectations of 53.5, suggesting growing optimism among consumers about the economic outlook, potentially driving future consumption.
  • Global Market Synchronization: European and Chinese stock markets rallied in tandem, contributing to gains in the US stock market, reflecting the potential for global economic recovery and further enhancing investor risk appetite.
NASDAQ.COM
4.0
01-09NASDAQ.COM
Trump Proposes $200 Billion Mortgage Bond Purchase to Boost Housing Demand
  • Housing Market Boost: President Trump proposed that Fannie Mae and Freddie Mac purchase $200 billion in mortgage bonds to lower long-term rates and stimulate housing demand, which could lead to a recovery in the construction sector and an increase in related stock prices.
  • Employment Data Impact: U.S. nonfarm payrolls rose by 50,000 in December, below the expected 70,000, although the unemployment rate fell to 4.4%, indicating labor market resilience that may influence the Fed's monetary policy direction.
  • Consumer Confidence Rise: The University of Michigan's consumer sentiment index rose to 54.0 in January, exceeding expectations of 53.5, suggesting that consumer optimism about the economic outlook could boost spending.
  • Global Market Linkage: U.S. stocks are supported by rallies in global equity markets, with Europe’s Euro Stoxx 50 reaching a new record high and China’s Shanghai Composite Index climbing to a 10.5-year high, reflecting positive sentiment in international markets impacting the U.S. market.
NASDAQ.COM
4.0
01-09NASDAQ.COM
Trump Proposes $200 Billion Mortgage Bond Purchase to Boost Housing Demand
  • Housing Market Stimulus: President Trump proposed that Fannie Mae and Freddie Mac purchase $200 billion in mortgage bonds to lower long-term rates and stimulate housing demand, potentially reviving the construction sector.
  • Employment Data Insight: The U.S. added 50,000 nonfarm jobs in December, falling short of the 70,000 expected, while the unemployment rate dropped to 4.4%, indicating labor market resilience that may influence future monetary policy.
  • Building Permit Growth: Despite October housing starts unexpectedly falling to a 5.5-year low, building permits rose to 1.412 million, exceeding expectations of 1.35 million, suggesting a potential rebound in future construction activity.
  • Global Market Impact: U.S. stocks are buoyed by a rebound in global markets, with the Euro Stoxx 50 reaching a new record high, reflecting international investor confidence in the U.S. economy, which may further drive capital inflows.
Wall Street analysts forecast HQY stock price to rise
11 Analyst Rating
Wall Street analysts forecast HQY stock price to rise
9 Buy
1 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
89.00
Averages
117.09
High
129.00
Current: 0.000
sliders
Low
89.00
Averages
117.09
High
129.00
BMO Capital
Market Perform
downgrade
$100 -> $85
AI Analysis
2026-02-24
Reason
BMO Capital
Price Target
$100 -> $85
AI Analysis
2026-02-24
downgrade
Market Perform
Reason
BMO Capital lowered the firm's price target on HealthEquity to $85 from $100 and keeps a Market Perform rating on the shares. The firm believes that the company will continue to leverage its scale to expand its leading position in the growing HSA end market and drive service costs lower via technology while benefiting near term from additional custodial revenue growth as cash assets are re-priced at higher interest rates, though its price target cut reflects the recent valuation compression across the peer group, the analyst tells investors in a research note.
Jefferies
Buy
downgrade
$120 -> $108
2026-02-19
Reason
Jefferies
Price Target
$120 -> $108
2026-02-19
downgrade
Buy
Reason
Jefferies lowered the firm's price target on HealthEquity to $108 from $120 and keeps a Buy rating on the shares. Pre-released Q4 operational metrics show "strong" HSA account growth of 6.9% year-over-year and asset growth of 13.6% year-over-year, notes the analyst, who believe that the stock is "a great defensive option" for investors who want to maintain exposure to healthcare and/or tech but without the AI risk to its business model.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HQY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Healthequity Inc (HQY.O) is 22.01, compared to its 5-year average forward P/E of 34.26. For a more detailed relative valuation and DCF analysis to assess Healthequity Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
34.26
Current PE
22.01
Overvalued PE
45.90
Undervalued PE
22.63

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
18.80
Current EV/EBITDA
17.87
Overvalued EV/EBITDA
22.67
Undervalued EV/EBITDA
14.93

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
6.09
Current PS
6.78
Overvalued PS
7.01
Undervalued PS
5.17

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks likely to go up 2% tomorrow morning
Intellectia · 12 candidates
Market Cap: >= 2.00BMoving Average Relationship: PriceAboveMA20One Day Rise Prob: >= 70One Day Predict Return: >= 2.0%Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
HCC logo
HCC
Warrior Met Coal Inc
4.24B
GD logo
GD
General Dynamics Corp
96.15B
FUTU logo
FUTU
Futu Holdings Ltd
21.38B
HQY logo
HQY
Healthequity Inc
6.71B
FIVE logo
FIVE
Five Below Inc
12.19B
ETOR logo
ETOR
eToro Group Ltd
2.50B
What stock has the most upside this 2026?
Intellectia · 48 candidates
Market Cap: 1000.00M - 100.00BAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 10List Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePrice
Ticker
Name
Market Cap$
top bottom
KSPI logo
KSPI
Kaspi.kz AO
15.02B
QFIN logo
QFIN
Qfin Holdings Inc
2.14B
NICE logo
NICE
Nice Ltd
7.07B
PTC logo
PTC
PTC Inc
19.28B
JD logo
JD
JD.com Inc
42.34B
TW logo
TW
Tradeweb Markets Inc
24.31B
rerun right now to see if the list changes
Intellectia · 29 candidates
Price: $3.00 - $100.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEOne Day Rise Prob: >= 60One Day Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SIDU logo
SIDU
Sidus Space Inc
234.80M
DBGI logo
DBGI
Digital Brands Group Inc (Pre-Reincorporation)
68.45M
MED logo
MED
Medifast Inc
128.60M
AAP logo
AAP
Advance Auto Parts Inc
2.75B
CMBT logo
CMBT
CMB.TECH NV
3.30B
LSTA logo
LSTA
Lisata Therapeutics Inc
35.81M
show me more stocks like alit
Intellectia · 17 candidates
Market Cap: 3.00B - 12.00BRevenue Ttm: 1000.00M - 4.00BRegion: USWeekly Average Turnover: >= 3,000,000Annual Revenue Yoy Growth: 10.0% - 30.0%
Ticker
Name
Market Cap$
top bottom
BSY logo
BSY
Bentley Systems Inc
11.98B
NTNX logo
NTNX
Nutanix Inc
11.24B
CFLT logo
CFLT
Confluent Inc
10.82B
CART logo
CART
Maplebear Inc
10.24B
MANH logo
MANH
Manhattan Associates Inc
10.01B
PCOR logo
PCOR
Procore Technologies Inc
9.79B

Whales Holding HQY

W
Wasatch Advisors LP
Holding
HQY
+8.61%
3M Return
S
Stephens Investment Management Group, LLC
Holding
HQY
+7.72%
3M Return
W
Westfield Capital Management Company, L.P.
Holding
HQY
+7.28%
3M Return
A
Aristotle Capital Boston, LLC
Holding
HQY
+0.84%
3M Return
E
Eversept Partners, L.P.
Holding
HQY
-0.96%
3M Return
C
Canada Life Investment Management Ltd.
Holding
HQY
-2.50%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Healthequity Inc (HQY) stock price today?

The current price of HQY is 78.57 USD — it has increased 0.09

What is Healthequity Inc (HQY)'s business?

HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.

What is the price predicton of HQY Stock?

Wall Street analysts forecast HQY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HQY is117.09 USD with a low forecast of 89.00 USD and a high forecast of 129.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Healthequity Inc (HQY)'s revenue for the last quarter?

Healthequity Inc revenue for the last quarter amounts to 322.16M USD, increased 7.23

What is Healthequity Inc (HQY)'s earnings per share (EPS) for the last quarter?

Healthequity Inc. EPS for the last quarter amounts to 0.59 USD, increased 883.33

How many employees does Healthequity Inc (HQY). have?

Healthequity Inc (HQY) has 3105 emplpoyees as of March 12 2026.

What is Healthequity Inc (HQY) market cap?

Today HQY has the market capitalization of 6.71B USD.